(MedPage Today) — Private equity acquisition of opioid treatment programs did not appear to increase the methadone supply, according to a difference-in-differences study.
While opioid treatment programs acquired by private equity firms had a…
Source link : https://www.medpagetoday.com/publichealthpolicy/opioids/117296
Author :
Publish date : 2025-09-03 20:35:00
Copyright for syndicated content belongs to the linked Source.
